RepSox (ALK5 Inhibitor): Potent, Selective TGF-β Signaling Control in Stem Cell Reprogramming

Executive Summary: RepSox (SKU: A3754) is a chemically defined, potent, and selective small molecule inhibitor of the TGF-β type I receptor ALK5 (TGFβR-1), with an IC₅₀ of 4 nM under in vitro kinase assay conditions (APExBIO). RepSox inhibits TGF-β/Smad signaling, relieving repression of key reprogramming genes such as Id1–3 and Nanog. In mouse embryonic fibroblasts, RepSox elevates L-Myc expression fivefold and supports Oct4/Klf4/cMyc-driven iPSC generation (Yue et al. 2026). RepSox-reprogrammed iPSCs contribute to mosaic embryos and adult chimeras, demonstrating in vivo functionality. The compound is used at 25 μM for 3-day culture periods and requires DMSO or ethanol for solubilization. RepSox is for research use only and is not for diagnostic or therapeutic applications.

Biological Rationale

TGF-β signaling orchestrates cell differentiation, transformation, and proliferation in both normal and pathological contexts (Yue et al. 2026). Its canonical pathway involves ALK5 (TGFβR-1), a serine/threonine kinase receptor. In stem cell biology, TGF-β maintains somatic cell identity and represses factors essential for pluripotency induction, such as Nanog and L-Myc. Inhibiting TGFβR-1 can therefore facilitate reprogramming and lineage transitions. RepSox is designed to target this bottleneck with high specificity and potency, providing a chemical tool to dissect or redirect fate decisions in cell systems. This rationale underlies its adoption in workflows for induced pluripotent stem cell (iPSC) generation, cancer biology, and studies of cellular plasticity (see also: RepSox—Advancing Chemical Control of Stem Cell Fate; this article extends previous mechanistic overviews by synthesizing recent quantitative benchmarks and highlighting translational parameters).

Mechanism of Action of RepSox (ALK5 inhibitor, potent and selective)

RepSox (2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine) selectively inhibits ALK5, the TGF-β type I receptor, with an IC₅₀ of 4 nM according to biochemical assays (APExBIO). ALK5 inhibition blocks phosphorylation of Smad2/3, halting canonical TGF-β/Smad signal transduction. This releases repression on Id gene family members (Id1, Id2, Id3), Nanog, and other pluripotency regulators. In mouse embryonic fibroblasts (MEFs), RepSox treatment at 25 μM for 3 days leads to a fivefold increase in L-Myc mRNA expression, enabling efficient iPSC reprogramming when combined with Oct4, Klf4, and cMyc. In vivo, iPSCs generated with RepSox contribute robustly to mosaic murine embryos and adults, validating its biological efficacy (Yue et al. 2026).

Evidence & Benchmarks

• RepSox displays an in vitro ALK5 (TGFβR-1) kinase inhibitory IC₅₀ of 4 nM (DMSO, 25°C; APExBIO product page).
• In MEF cultures, 25 μM RepSox for 3 days increases L-Myc (Mycl) mRNA expression by 5x relative to untreated controls (RT-qPCR; Yue et al. 2026).
• RepSox-induced iPSCs (with Oct4, Klf4, cMyc) form teratomas and contribute to chimeric mice in vivo (blastocyst injection; Yue et al. 2026).
• RepSox replaces Sox2 in reprogramming cocktails by inducing Nanog expression (cell culture, gene expression analysis; internal: RepSox—iPSC Reprogramming Precision).
• RepSox is insoluble in water but dissolves in DMSO (≥14.35 mg/mL) and ethanol (≥47.9 mg/mL, gentle warming) for experimental use (APExBIO).
• Optimized platelet production protocols from iPSCs employ small molecule TGF-β inhibitors, including RepSox analogs, to enhance yield and reduce costs (platelet differentiation platform; Yue et al. 2026).
• RepSox solution storage is unstable; fresh preparation is recommended for each experiment (manufacturer guidance; APExBIO).

Applications, Limits & Misconceptions

RepSox is primarily applied in:

• Induced pluripotent stem cell (iPSC) reprogramming: Replaces Sox2 and/or enhances efficiency via Nanog/L-Myc induction (see: RepSox—Strategic Disruption of TGF-β Signaling; this article provides updated quantitative evidence and translational guidance).
• Platelet and megakaryocyte differentiation: Used in cost-effective, scalable production platforms for ex vivo platelet generation from hiPSCs (Yue et al. 2026).
• Cancer research: Facilitates studies of TGF-β pathway function in tumor transformation, cell proliferation, and epigenetic regulation.
• Fibrosis and cell proliferation disorder models: As a TGF-β pathway inhibitor, RepSox is relevant for dissecting mechanisms in fibrotic diseases and related cell biology models.

Common Pitfalls or Misconceptions

• Not a general TGF-β family inhibitor: RepSox is highly selective for ALK5 (TGFβR-1) and does not broadly inhibit all TGF-β superfamily receptors.
• Water insolubility: RepSox must be solubilized in DMSO or ethanol—water-based stocks are ineffective and will precipitate.
• Not for clinical or diagnostic use: RepSox is strictly for laboratory research; it is not approved for human administration or medical diagnosis (APExBIO).
• Storage limitations: RepSox solutions degrade over time; do not store working solutions for extended periods.
• Context-dependent efficacy: Not all cell types respond identically to TGF-β inhibition; dose and timing require empirical validation for each context.

Workflow Integration & Parameters

For iPSC reprogramming, RepSox is typically added at 25 μM final concentration for 3 days to mouse embryonic fibroblast or human fibroblast cultures, in combination with reprogramming transcription factors (e.g., Oct4, Klf4, cMyc). For platelet and megakaryocyte differentiation, RepSox or similar TGF-β pathway inhibitors are included during key lineage specification windows, as defined by the protocol (Yue et al. 2026). DMSO or ethanol is used as solvent, and vehicle-only controls are essential for experimental rigor. RepSox powder should be aliquoted and stored at -20°C, protected from light and moisture. Working solutions should be prepared fresh immediately prior to use, as stability is limited. Users should consult the manufacturer's datasheet for lot-specific molecular weight and handling guidelines (RepSox (ALK5 inhibitor, potent and selective) product page).

Conclusion & Outlook

RepSox (A3754, APExBIO) stands as a benchmark tool for precise chemical inhibition of TGF-β/ALK5 signaling in stem cell biology, reprogramming, and translational platelet production. Its potency, selectivity, and well-characterized action facilitate reproducible, cost-effective workflows across basic and applied research. Ongoing protocol refinement and combinatorial strategies continue to expand its utility in regenerative medicine and disease modeling. For authoritative handling and mechanistic context, see RepSox—Transforming Stem Cell Reprogramming, which this article updates with recent cost and yield data from iPSC-platelet differentiation studies.